GEN-003 Phase 2 Interim Results: Therapeutic Vaccine for Genital Herpes Significantly Reduces Viral Shedding and Genital Lesions

RESULTS: Patient Demographics 898 1The University of Alabama at Birmingham, Birmingham, AL, 2Medical Center for Clinical Research, San Diego, CA, 3Tekton Research, Austin, TX, 4Westover Heights Clinic, Portland, OR, 5Center for Clinical Studies, Houston, TX, 6Cincinnati Childrenu0027s Hospital Medical Center, Cincinnati, OH, 7University of North Carolina, Chapel Hill, NC, 8Beth Israel Deaconess Medical Center, Boston, MA, 9Quest Clinical Research, San Francisco, CA, 10Indiana University School of Medicine, Indianapolis, IN, 11University of Illinois at Chicago, Chicago, IL, 12Magee Women’s Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA, 13University of Utah School of Medicine, Salt Lake City, UT, 14IND 2 Results LLC, Atlanta, GA , 15Genocea Biosciences, Cambridge, MA, 16University of Washington, Seattle, WA